Owlstone Medical Raises $6.5 Million for Breath Biopsy Research

Owlstone Medical's Funding and Research Projects

Key Highlights:

• Funding: Raised $6.5 million in funding, including a $5 million equity investment and a $1.5 million grant from the Bill & Melinda Gates Foundation.
• Breath Biopsy Platform: Advancements in the Breath Biopsy platform, including expanding the VOC Atlas database and developing a remote-use real-time breath analyzer.
• Research Projects: Two projects supported by the grant funding: identifying breath biomarkers for tuberculosis (TB) and HIV.

Owlstone Medical's Target Market

• Early Disease Detection: Focus on developing cost-effective detection technologies for volatile organic compounds (VOCs) as markers of diseases.
• Precision Medicine: Providing innovative solutions for precision medicine, particularly in the field of breath-based diagnostics.
• Global Health: Addressing diseases that disproportionately affect the developing world, such as TB and HIV.

What Owlstone Medical Needs to Buy

• Research and Development Partnerships: Collaborating with universities and research institutions to further develop breath-based diagnostics and identify disease biomarkers.
• Manufacturing and Supply Chain Solutions: Partnering with manufacturers to produce and distribute breath analysis devices and related products.
• Marketing and Distribution Support: Engaging with marketing agencies and distribution partners to reach healthcare providers and expand market reach.